Investigating the Efficacy of Probiotics in Enhancing Gastrointestinal and Immunological Health
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-45
SponsorWecare Probiotics Co., Ltd.
About this trial
Evaluate the effectiveness and safety of Ligilactobacillus salivarius LS97 as a food supplement compared to a placebo in improving intestinal and immune functions in healthy adults.
Eligibility criteria
Qualifiers
Willing to undergo 3 follow-up visits during the intervention period
Be willing to provide blood, urine and stool samples 2 times during the intervention period
Good eyesight, can read and write, can wear glasses
Have good hearing and be able to hear and understand all instructions during the intervention
Disqualifiers
Digestive diseases, mainly gastrointestinal diseases (celiac disease, ulcerative colitis, Crohn's disease)
Have a serious neurological condition (epilepsy, stroke, severe head trauma, meningitis in the last 10 years, brain surgery, brain tumor prolonged coma - not including general anaesthesia)
Have received/are receiving treatment for the following mental disorders: alcohol/drug/substance abuse dependence, schizophrenia psychosis, bipolar disorder
Take medication for depression or low mood
Trial design
Treatments tested in this trial
- Probiotic
- Placebo
Treatment groups
40 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov